Women’s Health

March 16, 2023

Study seeks to identify prenatal allergy risk markers

A Vanderbilt clinical trial is seeking to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions.

By Jessica Pasley
February 23, 2023

Study sheds new light on hormone therapy as menopause treatment

Vanderbilt research shows that hormone replacement therapy can be safely administered depending on the method used and the patient’s age, time since menopause, and risk of cardiovascular disease.

By Matt Batcheldor
February 16, 2023

Penicillin allergy test recommended for pregnant women

Vanderbilt experts say getting rid of unnecessary penicillin allergy labels allows women to receive better treatments for common infections during pregnancy and delivery.

By Kylie Avery
November 10, 2022

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

By Nancy Humphrey
August 17, 2022

Lindley named to direct new multidisciplinary Women’s Heart Center

Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.

By Matt Batcheldor
Pregnant woman holding pill pack
August 2, 2022

Targeted cancer drug during pregnancy

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

By Leigh MacMillan
July 15, 2022

VUMC, Tennova Healthcare – Clarksville collaborate to provide OB-GYN hospitalist care

Expectant women in Clarksville, Montgomery County and the surrounding area will soon benefit from around-the-clock, enhanced medical care during their labor and delivery through a collaboration between Vanderbilt University Medical Center and Tennova Healthcare - Clarksville to establish an OB-GYN hospitalist program.
By Jill Clendening
July 6, 2022

Study shows two vaccine doses for mothers eases COVID complications for infants

Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.
By Jessica Pasley
June 9, 2022

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.
By Jake Lowary
May 24, 2022

Vanderbilt Center for Women’s Health merges with Women’s Health Center of Lebanon

Vanderbilt Center for Women’s Health will merge with Women’s Health Center of Lebanon (WHCL) on May 28, expanding access to care.
By Emily Stembridge
April 26, 2022

Calculating risk for uterine fibroids

Vanderbilt researchers have constructed a polygenic risk score for uterine fibroids that will be useful for exploring causes of these benign tumors and identifying novel drug targets and therapies.
By Leigh MacMillan
March 28, 2022

Rheumatoid arthritis: special deliveries

Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
By Bill Snyder
March 15, 2022

Improving care for gynecologic cancer

To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.
By Emily Stembridge
1 2 3 4 5 … 10